Loading…
Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment
Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alter...
Saved in:
Published in: | Cell death & disease 2021-07, Vol.12 (8), p.752-752, Article 752 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653 |
---|---|
cites | cdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653 |
container_end_page | 752 |
container_issue | 8 |
container_start_page | 752 |
container_title | Cell death & disease |
container_volume | 12 |
creator | Chen, Yanyan Huang, Mengxi Liu, Xiaolong Huang, Yadi Liu, Chao Zhu, Jialong Fu, Gongbo Lei, Zengjie Chu, Xiaoyuan |
description | Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed. |
doi_str_mv | 10.1038/s41419-021-04031-w |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_90ceeefbcf9a4f2084068daf9cb42aed</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_90ceeefbcf9a4f2084068daf9cb42aed</doaj_id><sourcerecordid>2557233368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEolXpH-CALHHhEvBXEpsD0qrio1IFEoKzNXEmwavEXmxvV_33mE0pLQd8sEeeZ17PyG9VPWf0NaNCvUmSSaZryllNJRWsPjyqTjmVrJZK6cf34pPqPKUtLUsIypv2aXUiZAmV5qeV3cwZo4fsrpGk3eys8xMJI1m-ft4Q54kNc4hoM8zEgrcY3xKPB5JyhIyTw0TGEEneL2UfHEw-JJcI-IHkiJAX9PlZ9WSEOeH57XlWff_w_tvFp_rqy8fLi81VbRtJcw2ctlbbFnlT2qad4iC7RlrkTHeCsqFTlnPNOwU973s2sAYtsFHwQXFsG3FWXa66Q4Ct2UW3QLwxAZw5XoQ4GYjZ2RmNphYRx96OGuTIqZK0VQOM2vaSAw5F692qtdv3Cw62jBFhfiD6MOPdDzOFa6MEl6pVReDVrUAMP_eYsllcsjjP4DHsk-FN03EhxBF9-Q-6DfvyJ_ORahupmZKF4itlY0gp4njXDKPmtyXMaglTLGGOljCHUvTi_hh3JX8MUACxAqmk_ITx79v_kf0F2t7DEg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2556549184</pqid></control><display><type>article</type><title>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</title><source>Open Access: PubMed Central</source><source>Access via ProQuest (Open Access)</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Chen, Yanyan ; Huang, Mengxi ; Liu, Xiaolong ; Huang, Yadi ; Liu, Chao ; Zhu, Jialong ; Fu, Gongbo ; Lei, Zengjie ; Chu, Xiaoyuan</creator><creatorcontrib>Chen, Yanyan ; Huang, Mengxi ; Liu, Xiaolong ; Huang, Yadi ; Liu, Chao ; Zhu, Jialong ; Fu, Gongbo ; Lei, Zengjie ; Chu, Xiaoyuan</creatorcontrib><description>Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed.</description><identifier>ISSN: 2041-4889</identifier><identifier>EISSN: 2041-4889</identifier><identifier>DOI: 10.1038/s41419-021-04031-w</identifier><identifier>PMID: 34330892</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>38 ; 38/91 ; 631/337 ; 631/67/2324 ; 631/80 ; Alternative splicing ; Alternative Splicing - genetics ; Animals ; Antibodies ; Apoptosis - genetics ; Biochemistry ; Biomedical and Life Sciences ; Cancer ; Cell Biology ; Cell Culture ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - blood supply ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - therapy ; Gene regulation ; Humans ; Immunology ; Life Sciences ; Post-transcription ; Protein Processing, Post-Translational ; Review ; Review Article ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Spliceosomes - metabolism</subject><ispartof>Cell death & disease, 2021-07, Vol.12 (8), p.752-752, Article 752</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</citedby><cites>FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2556549184/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2556549184?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34330892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Yanyan</creatorcontrib><creatorcontrib>Huang, Mengxi</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><creatorcontrib>Huang, Yadi</creatorcontrib><creatorcontrib>Liu, Chao</creatorcontrib><creatorcontrib>Zhu, Jialong</creatorcontrib><creatorcontrib>Fu, Gongbo</creatorcontrib><creatorcontrib>Lei, Zengjie</creatorcontrib><creatorcontrib>Chu, Xiaoyuan</creatorcontrib><title>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</title><title>Cell death & disease</title><addtitle>Cell Death Dis</addtitle><addtitle>Cell Death Dis</addtitle><description>Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed.</description><subject>38</subject><subject>38/91</subject><subject>631/337</subject><subject>631/67/2324</subject><subject>631/80</subject><subject>Alternative splicing</subject><subject>Alternative Splicing - genetics</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Apoptosis - genetics</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - blood supply</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - therapy</subject><subject>Gene regulation</subject><subject>Humans</subject><subject>Immunology</subject><subject>Life Sciences</subject><subject>Post-transcription</subject><subject>Protein Processing, Post-Translational</subject><subject>Review</subject><subject>Review Article</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Spliceosomes - metabolism</subject><issn>2041-4889</issn><issn>2041-4889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1v1DAQhiMEolXpH-CALHHhEvBXEpsD0qrio1IFEoKzNXEmwavEXmxvV_33mE0pLQd8sEeeZ17PyG9VPWf0NaNCvUmSSaZryllNJRWsPjyqTjmVrJZK6cf34pPqPKUtLUsIypv2aXUiZAmV5qeV3cwZo4fsrpGk3eys8xMJI1m-ft4Q54kNc4hoM8zEgrcY3xKPB5JyhIyTw0TGEEneL2UfHEw-JJcI-IHkiJAX9PlZ9WSEOeH57XlWff_w_tvFp_rqy8fLi81VbRtJcw2ctlbbFnlT2qad4iC7RlrkTHeCsqFTlnPNOwU973s2sAYtsFHwQXFsG3FWXa66Q4Ct2UW3QLwxAZw5XoQ4GYjZ2RmNphYRx96OGuTIqZK0VQOM2vaSAw5F692qtdv3Cw62jBFhfiD6MOPdDzOFa6MEl6pVReDVrUAMP_eYsllcsjjP4DHsk-FN03EhxBF9-Q-6DfvyJ_ORahupmZKF4itlY0gp4njXDKPmtyXMaglTLGGOljCHUvTi_hh3JX8MUACxAqmk_ITx79v_kf0F2t7DEg</recordid><startdate>20210730</startdate><enddate>20210730</enddate><creator>Chen, Yanyan</creator><creator>Huang, Mengxi</creator><creator>Liu, Xiaolong</creator><creator>Huang, Yadi</creator><creator>Liu, Chao</creator><creator>Zhu, Jialong</creator><creator>Fu, Gongbo</creator><creator>Lei, Zengjie</creator><creator>Chu, Xiaoyuan</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210730</creationdate><title>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</title><author>Chen, Yanyan ; Huang, Mengxi ; Liu, Xiaolong ; Huang, Yadi ; Liu, Chao ; Zhu, Jialong ; Fu, Gongbo ; Lei, Zengjie ; Chu, Xiaoyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>38</topic><topic>38/91</topic><topic>631/337</topic><topic>631/67/2324</topic><topic>631/80</topic><topic>Alternative splicing</topic><topic>Alternative Splicing - genetics</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Apoptosis - genetics</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - blood supply</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - therapy</topic><topic>Gene regulation</topic><topic>Humans</topic><topic>Immunology</topic><topic>Life Sciences</topic><topic>Post-transcription</topic><topic>Protein Processing, Post-Translational</topic><topic>Review</topic><topic>Review Article</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Spliceosomes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yanyan</creatorcontrib><creatorcontrib>Huang, Mengxi</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><creatorcontrib>Huang, Yadi</creatorcontrib><creatorcontrib>Liu, Chao</creatorcontrib><creatorcontrib>Zhu, Jialong</creatorcontrib><creatorcontrib>Fu, Gongbo</creatorcontrib><creatorcontrib>Lei, Zengjie</creatorcontrib><creatorcontrib>Chu, Xiaoyuan</creatorcontrib><collection>Springer Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cell death & disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yanyan</au><au>Huang, Mengxi</au><au>Liu, Xiaolong</au><au>Huang, Yadi</au><au>Liu, Chao</au><au>Zhu, Jialong</au><au>Fu, Gongbo</au><au>Lei, Zengjie</au><au>Chu, Xiaoyuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</atitle><jtitle>Cell death & disease</jtitle><stitle>Cell Death Dis</stitle><addtitle>Cell Death Dis</addtitle><date>2021-07-30</date><risdate>2021</risdate><volume>12</volume><issue>8</issue><spage>752</spage><epage>752</epage><pages>752-752</pages><artnum>752</artnum><issn>2041-4889</issn><eissn>2041-4889</eissn><abstract>Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>34330892</pmid><doi>10.1038/s41419-021-04031-w</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2041-4889 |
ispartof | Cell death & disease, 2021-07, Vol.12 (8), p.752-752, Article 752 |
issn | 2041-4889 2041-4889 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_90ceeefbcf9a4f2084068daf9cb42aed |
source | Open Access: PubMed Central; Access via ProQuest (Open Access); Springer Nature - nature.com Journals - Fully Open Access |
subjects | 38 38/91 631/337 631/67/2324 631/80 Alternative splicing Alternative Splicing - genetics Animals Antibodies Apoptosis - genetics Biochemistry Biomedical and Life Sciences Cancer Cell Biology Cell Culture Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - blood supply Colorectal Neoplasms - diagnosis Colorectal Neoplasms - genetics Colorectal Neoplasms - therapy Gene regulation Humans Immunology Life Sciences Post-transcription Protein Processing, Post-Translational Review Review Article RNA, Messenger - genetics RNA, Messenger - metabolism Spliceosomes - metabolism |
title | Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternative%20splicing%20of%20mRNA%20in%20colorectal%20cancer:%20new%20strategies%20for%20tumor%20diagnosis%20and%20treatment&rft.jtitle=Cell%20death%20&%20disease&rft.au=Chen,%20Yanyan&rft.date=2021-07-30&rft.volume=12&rft.issue=8&rft.spage=752&rft.epage=752&rft.pages=752-752&rft.artnum=752&rft.issn=2041-4889&rft.eissn=2041-4889&rft_id=info:doi/10.1038/s41419-021-04031-w&rft_dat=%3Cproquest_doaj_%3E2557233368%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2556549184&rft_id=info:pmid/34330892&rfr_iscdi=true |